Monthly Archives: January 2012

These articles were announced as commencing production during the month of January 2012:Biomarker InsightsDetection of 1p19q deletion by real-time comparative quantitative PCRBreast Cancer: Basic and C…

Introduction: Current guidelines recommend completion axillary lymph node dissection (cALND) in case of a sentinel lymph node (SLN) metastasis larger than 0.2 mm. However, in 50%–65% of these patients, the non-SLNs contain no further metastases and…

(MedPage Today) — Almost a quarter of breast cancer lumpectomies are followed by revision surgery, although that rate varies widely across surgeons and centers.

PHOENIX (MedPage Today) — Head and neck cancer patients had pretreatment neurocognitive function similar to that of healthy controls but thought it was worse, a prospective study indicated.

PHOENIX (MedPage Today) — Intensity modulated radiation therapy was better than other treatments in boosting long-term quality of life in head-and-neck cancer patients, investigators reported here.

PHOENIX (MedPage Today) — Patients with head and neck cancer had substantial sparing of oral mucosa when they used custom-made dental stents to shield normal tissue from radiation therapy, data from a small clinical series showed.

WASHINGTON (MedPage Today) — The FDA has approved the first drug for treatment of basal cell carcinoma, the most common type of skin cancer.

(MedPage Today) — The maker of bendamustine HCL injection (Treanda) has recalled a single product lot due to the presence of glass particles, which may cause disruption of blood flow and emboli.

PHOENIX (MedPage Today) — Osteoradionecrosis of the jaw occurred more than twice as often in patients treated for oral cancer as reported in the literature, according to a population-based study.

PHOENIX (MedPage Today) — Patients with advanced nasopharyngeal carcinoma achieved favorable overall survival when bevacizumab was added to upfront and adjuvant therapy, results of a preliminary cooperative group trial showed.